With regard to the next step in 355's development, Chang says, "No one has tens of millions of US dollars just lying around. So we'll take the Phase II results and either seek a partnership with a major pharmaceuticals makers, or sell the rights outright."
關於「355」的下一步，張念原說：「沒有人可以一下子拿出數千萬美元，所以我們將視第二期臨床試驗的結果，再找國際大廠結盟或授權出去。」